PRAXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Praxis Precision Medicines, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$260.17+18.41 (+7.61%)
Close on Oct 19, 2026
- Market cap
- $7.58B
- P/E (TTM)
- –
- Dividend yield
- –
Praxis Precision Medicines statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Praxis Precision Medicines | Industry median |
|---|---|---|
| Market Cap | $7.26B | $197.05M |
| Enterprise Value | $5.86B | $106.56M |
| PB Ratio | 5.42 | 2.14 |
| P/TBV Ratio | 5.42 | 2.46 |
Income (trailing twelve months)
| Measure | Praxis Precision Medicines | Industry median |
|---|---|---|
| Operating Income | -$378.17M | -$21.44M |
| Net Income | -$339.13M | -$22.46M |
| EBITDA | -$378.17M | -$16.91M |
| EPS (Diluted) | -$12.92 | -$0.83 |
Returns
| Measure | Praxis Precision Medicines | Industry median |
|---|---|---|
| Return on Equity (ROE) | -38.9% | -53.1% |
| Return on Assets (ROA) | -36.8% | -41.0% |
| Return on Capital Employed (ROCE) | -28.2% | -37.8% |
Balance sheet
| Measure | Praxis Precision Medicines | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $1.40B | $62.42M |
| Net Cash (Debt) | $1.40B | $15.68M |
| Net Cash Per Share | $50.14 | $0.65 |
| Equity (Book Value) | $1.34B | $48.79M |
| Book Value Per Share | $48.03 | $1.36 |
| Tangible Book Value | $1.34B | $23.06M |
| Working Capital | $722.85M | $75.77M |
Financial position
| Measure | Praxis Precision Medicines | Industry median |
|---|---|---|
| Current Ratio | 15.73 | 3.30 |
| Quick Ratio | 28.54 | 2.39 |
Cash flow (trailing twelve months)
| Measure | Praxis Precision Medicines | Industry median |
|---|---|---|
| Operating Cash Flow | -$305.08M | -$12.35M |
| Capital Expenditures | -$307.00K | -$1.06M |
| Free Cash Flow | -$305.38M | -$20.28M |
| FCF Per Share | -$10.94 | -$0.41 |
Efficiency
| Measure | Praxis Precision Medicines | Industry median |
|---|---|---|
| Profits Per Employee | -$2.02M | -$732.08K |
| Employee Count | 168 | 73 |
Dividends and yields
| Measure | Praxis Precision Medicines | Industry median |
|---|---|---|
| Earnings Yield | -4.67% | -21.2% |
| FCF Yield | -4.20% | -7.64% |
Shares
| Measure | Praxis Precision Medicines | Industry median |
|---|---|---|
| Shares Outstanding | 27,920,000 | 59,128,900 |
| Shares Change (YoY) | 29.6% | 11.1% |
| Shares Change (QoQ) | 0.20% | 0.54% |
| Float | 27,719,000 | 48,744,500 |
| Shares Held by Insiders | 0.72% | 11.8% |
| Shares Held by Institutions | 120.8% | 59.4% |
Scores
| Measure | Praxis Precision Medicines | Industry median |
|---|---|---|
| Altman Z-Score | 87.24 | 0.10 |
| Piotroski F-Score | 3 | 4 |
Calculated by StockData from Praxis Precision Medicines's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.